netFormulary Oxford Health NHS Foundation Trust NHS
Formulary  
 Search
 Formulary Chapter 17: COVID-19 - useful medicines information - Full Section
 Useful Links
Link   ACEIs & ARBs: ACE-Inhibitors / Angiotensin Receptor Blockers and coronavirus - Position Statement from the European Society of Cardiology Council on Hypertension
Link   AGITATED BEHAVIOUR: Managing acutely disturbed behaviour in the context of COVID-19: National Association of Psychiatric Intensive Care & Low Secure Units
Link   ANTIPSYCHOTIC LAIs: Guidance on amending the dosing interval of antipsychotic long-acting injections (LAIs)
Link   CHLOROQUINE and HYDROXYCHLOROQUINE: MHRA statement
Link   CLOZAPINE: Coronavirus (COVID-19) and clozapine - information for Healthcare Professionals VERSION 3
Link   CLOZAPINE: DMS off-label clozapine form
Link   CLOZAPINE: Information for patients: Clozapine, blood testing and the coronavirus/COVID-19 outbreak
Link   CONTROLLED DRUGS: CD reconciliation policy during COVID-19 outbreak - reduced frequency
Link   DELIRIUM: Delirium management and COVID-19 (coronavirus)
Link   END OF LIFE CARE: Oxfordshire Guidelines for End of Life Symptom Management during the coronavirus outbreak (COVID-19)
Link   GENERAL: COVID-19 guidance and information for different medicines and medical specialties (from Specialist Pharmacy Service)
Link   LITHIUM: Lithium monitoring and COVID-19 VERSION 2
Link   MEDICAL SPECIALITIES: Links by specialty to national COVID-19 guidance related to medicines
Link   NICE: COVID-19 guidance from NICE
Link   NSAIDS: Coronavirus and anti-inflammatories - NHS Medical Director updated advice to clinical staff April 14th
Link   OLANZAPINE LONG ACTING INJECTION (OLAI): Guidance for managing the 3 hours of monitoring during the coronavirus (COVID19) outbreak
Link   OXYGEN: BOC medical oxygen supply plans during coronavirus (COVID-19) outbreak
Link   OXYGEN: Increased demand on medical oxygen supply systems - management of ice build up
Link   REMOTE PRESCRIBING: Guidance to clinicians who are prescribing remotely to outpatients VERSION 2
Link   REMOTE PRESCRIBING: Inpatient PRN chart
Link   REMOTE PRESCRIBING: NRT inpatient PRN prescription
Link   REMOTE PRESCRIBING: PRN paracetamol inpatient chart
Link   RETURN OF MEDICATION: Guidance about the return of medicines to Pharmacy and disposal of medicines during COVID-19
Link   SMOKING CESSATION: Enforced abstinence protocol (updated for coronavirus outbreak)
Link   SMOKING CESSATION: The effects on psychotropic medication
Link   VALPROATE: Temporary MHRA guidance for managing the Pregnancy Prevention Programme during the pandemic
Link   VITAMIN D: A rapid review of the evidence for treatment or prevention in COVID-19 [CEBM]
Link   VTE PREVENTION: Changes to dalteparin dosing recommendations in confirmed or suspected COVID positive patients
Link   WARD POLICY: Non-pharmacy dispensing of medication (TTOs) extended from 3 days to 14 days during COVID-19 outbreak
Link   WARFARIN: Guidance on safe switching from warfarin to Direct Oral Anticoagulants (DOACs) for patients with non-valvular AFand venous thromboembolism (DVT/ PE) during coronavirus pandemic
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
17 (0,0)
netFormulary